drug protocol number

E2422

drug sponsor

Novartis

drug study

Exjade (Deferasirox)

drug trial site

King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Jeddah), King Khalid University Hospital (Riyadh)

drug status

Ongoing

drug phase